Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The aim of this research is to explore the efficacy of the opiate antagonist, naltrexone as
combined with CBT-intervention in the treatment of pathological gambling (PG). The study
period is 2011-2014 during which one hundred Pathological Gamblers will be recruited to
participate to this placebo-controlled double-blind trial.
Phase:
Phase 4
Details
Lead Sponsor:
Finnish Institute for Health and Welfare National Institute for Health and Welfare, Finland